|
- Biologicals - World Health Organization (WHO)
Biologicals are a class of medicines made from living cells taken from plants, animals or bacteria These cells are use in creating many types of health care products, including vaccines This group of medicines also includes products derived from human blood and plasma for the treatment of many life-threatening diseases and for surgical procedures
- Guidelines for Biologicals - World Health Organization (WHO)
Home Teams Technical standards and specifications Norms and standards for Biological Products Guidelines for Biologicals
- International Day for Biological Diversity: Harmony between nature and . . .
This year’s International Day for Biological Diversity, on Thursday, 22 May 2025, highlights the inherent connections between people and the natural world through the theme, “Harmony with nature and sustainable development” It underscores the need to achieve the Kunming-Montreal Global Biodiversity Framework (GBF) targets to halt and reverse biodiversity loss – interlinked with
- Chemical, Biological, Radiological and Nuclear (CBRN)
Chemical, Biological, Radiological and Nuclear (CBRN) capacities are specialized capacities which require highly specialized training to prepare and respond to natural, accidental and deliberate events
- Biotherapeutic products - World Health Organization (WHO)
A major industrial application of biotechnology is in the development and preparation of biological medicinal products using genetically engineered bacteria, yeast, fungi, cells or even whole animals and plants
- Safeguarding biosafety and biosecurity in laboratories
Biological agents which are capable of secondary transmission can lead to epidemics An attack involving a biological agent may mimic a natural event, which may complicate the public health assessment and response In case of war and conflict, high-threat pathogens laboratories can be targeted, which might lead to serious public health
- TRS 1060 - Annex 6: Guideline on bioanalytical method validation and . . .
This guideline is intended to provide recommendations for the validation of bioanalytical methods for chemical and biological drug quantification in biological matrices and their application in the analysis of study samples Adherence to the principles presented in this guideline will ensure the quality and consistency of the bioanalytical data in support of the development and market approval
- Regulation and quality control of vaccines
Regulation and quality control of vaccines Biological products, including vaccines, are distinguished from chemical pharmaceuticals by being derived from living organisms with a molecular composition too complex to be defined by physical or chemical means
|
|
|